Clinical Trials Logo

Filter by:
NCT ID: NCT00849602 Active, not recruiting - Dengue Clinical Trials

The Effect of Chloroquine in the Treatment of Patients With Dengue

Start date: February 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study was to evaluate the effect of chloroquine in the treatment of patients with dengue.

NCT ID: NCT00829166 Active, not recruiting - Breast Cancer Clinical Trials

An Open-label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine + Lapatinib in Patients With HER2-positive Locally Advanced or Metastatic Breast Cancer

EMILIA
Start date: February 2009
Phase: Phase 3
Study type: Interventional

This is a Phase III, randomized, multicenter, international, 2-arm, open-label clinical trial designed to compare the safety and efficacy of trastuzumab emtansine (T-DM1) with that of capecitabine + lapatinib for HER2-positive metastatic breast cancer (MBC). Patients were treated until disease progression, unmanageable toxicity, or study termination. Once disease progression was reported, all patients were followed for survival every 3 months until death, loss to follow-up, withdrawal of consent, or study termination.

NCT ID: NCT00820690 Active, not recruiting - Breast Cancer Clinical Trials

Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

LABC
Start date: July 2008
Phase: N/A
Study type: Observational

The purpose of this study is to analyze gene expression signature and immunohistochemical markers associated with clinical and pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.

NCT ID: NCT00813722 Active, not recruiting - Blood Pressure Clinical Trials

Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment

Start date: March 1999
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the importance of providing guidelines to patients via active telephone calls in blood pressure control and in the discontinuation of treatment among hypertensive patients. Hypertensives (N = 354) who could receive telephone calls to be reminded of the dates of their medical appointments and to be instructed about hypertension were distributed into two groups: a) "uncomplicated" - hypertensives with no other concurrent diseases; and b) "complicated" - severe hypertensives (mean diastolic ≥ 110 mm Hg with or without medication) or comorbidities. All patients, except those excluded (n=44), were open block randomized to follow two treatment regimens: "traditional" or "current" and to receive active telephone calls ("phone calls" group) or not to receive telephone calls ("no phone calls" group).

NCT ID: NCT00809575 Active, not recruiting - Clinical trials for Myelodysplastic Syndromes

Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes

PROMYS
Start date: October 2, 2008
Phase:
Study type: Observational

RATIONALE: Gathering information about quality of life, fatigue, and other symptoms from patients with myelodysplastic syndromes may help doctors learn more about the disease and may help plan treatment. PURPOSE: This clinical trial is studying quality of life and symptoms in patients with newly diagnosed myelodysplastic syndromes.

NCT ID: NCT00804037 Active, not recruiting - Apnea Clinical Trials

Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate

Start date: January 2007
Phase: N/A
Study type: Interventional

SUMMARY INTRODUCTION: among various treatments for patients with primary snoring, upper airway resistance syndrome (UARS) and obstructive sleep apnea syndrome (OSAS), the injection snoreplasty arose as a promising alternative in some selected cases. OBJECTIVE: to investigate the efficacy and tolerance of injection snoreplasty comparing Ethanol and Ethanolamine Oleate.

NCT ID: NCT00801450 Active, not recruiting - Clinical trials for Diabetic Macular Edema

Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery

Start date: September 2007
Phase: Phase 1/Phase 2
Study type: Interventional

Triamcinolone has already been used by different routes of administration to treat diabetic macular edema. In the present study, intravitreal injection (IVI) and posterior sub-Tenon's infusion (STI) of triamcinolone acetonide (TA) during phacoemulsification cataract surgery in eyes with refractory diffuse diabetic macular edema are tested.

NCT ID: NCT00797030 Active, not recruiting - Dry Eye Syndromes Clinical Trials

Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus

Start date: October 2006
Phase: Phase 4
Study type: Interventional

This study evaluates the use of topical cyclosporine 0.05% and sodium carboxymethylcellulose 0.5% for the treatment of dry eye disease in patients infected with the human immunodeficiency virus. Twenty HIV-positive-patients were selected from the Department of Infectious Diseases of the Federal University of Rio de Janeiro Hospital. Dry eye diagnosis was based on a dry eye questionnaire (Ocular Surface Disease Index - OSDI®), Schirmer I Test, break up time and 1% rose bengal staining of the ocular surface. The patients were divided into two groups with ten patients. Group I received sodium carboxymethylcellulose 0.5% drops and group II received sodium carboxymethylcellulose 0,5% drops and topical cyclosporine 0.05% for six months.

NCT ID: NCT00792779 Active, not recruiting - Hemolysis Clinical Trials

Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty

Start date: November 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if propofol could protect erythrocytes by directly scavenging free radicals from the blood current and increasing resistance of their cell membranes in patients submitted to gastroplasty.

NCT ID: NCT00791700 Active, not recruiting - Clinical trials for Human Immunodeficiency Virus

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Start date: April 22, 2009
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to determine the pharmacokinetic properties (what the body does to maraviroc) and to determine a suitable dosing schedule of maraviroc in HIV-1 infected children and adolescents. This study will also determine whether maraviroc is safe to use in children and adolescents.